Chronic Myeloid Leukemia, BCR-ABL1 Positive

Chronic Myeloid Leukemia, BCR-ABL1 Positive — Trials · CancerIndex

Clinical trials

Registered studies

649 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 102
Recruiting: 49
Ph III recruiting: 2
Growth YoY: —
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (104)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04595851	Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications	terminated	N/A	6	University of Michigan Rogel Cancer CenterOTHER	1	Nov 22, 2022	clinicaltrials
NCT01490775	Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy	terminated	N/A	27	Rex Cancer Center, Raleigh, NCOTHER	1	Aug 13, 2018	clinicaltrials